Healthy diet could save $50 billion in health care costs

December 17, 2019

Boston, MA -- An unhealthy diet is one of the leading risk factors for poor health, accounting for up to 45 percent of all deaths from cardiometabolic diseases (CMD), such as heart disease, stroke and type 2 diabetes. But the national economic burden of unhealthy diet habits remains unknown. A new study by investigators from Brigham and Women's Hospital, in collaboration with investigators at the Friedman School of Nutrition Science and Policy at Tufts University, analyzed the impact of 10 dietary factors -- including consumption of fruits and vegetables, nuts and seeds, processed meats and more -- and estimated the annual CMD costs of suboptimal diet habits. The team concludes that suboptimal diet costs approximately $300 per person, or $50 billion nationally, accounting for 18 percent of all heart disease, stroke and type 2 diabetes costs in the country. The team's findings are published in PLOS Medicine.

"There is a lot to be gained in terms of reducing risk and cost associated with heart disease, stroke and diabetes by making relatively simple changes to one's diet," said corresponding author Thomas Gaziano, MD, MSc, of the Division of Cardiovascular Medicine at the Brigham. "Our study indicates that the foods we purchase at the grocery store can have a big impact. I was surprised to see a reduction of as much as 20 percent of the costs associated with these cardiometabolic diseases."

To conduct their study, Gaziano and colleagues, including co-senior author Renata Micha, PhD, an associate research professor at Tufts, focused on the impact of 10 food groups -- fruits, vegetables, nuts/seeds, whole grains, unprocessed red meats, processed meats, sugar-sweetened beverages, polyunsaturated fats, seafood omega-3 fats and sodium). Using data from the National Health and Nutrition Examination Survey (NHANES), the team created a representative U.S. population sample of individuals aged 35-85 years. Using a model they developed and termed the CVD PREDICT model, the team analyzed individual risk of cardiometabolic disease and associated costs for the sample population based on respondents' current dietary patterns. They then re-calculated costs for CMD if everyone's diet was optimized to the healthiest amounts of the 10 foods and nutrients.

The team found that suboptimal diets account for $301 per person in terms of CMD-related costs. This translates to more than $50 billion nationally, 84 percent of which is due to acute care. Costs were highest for those with Medicare ($481/person) and those who were eligible for both Medicare and Medicaid ($536/person).

"We have accumulating evidence from the Food-PRICE collaborative research work to support policy changes focused on improving health at a population level. One driver for those changes is identifying the exorbitant economic burden associated with chronic disease caused by our poor diets. This study provides additional evidence that those costs are unacceptable. While individuals can and do make changes, we need innovative new solutions - incorporating policy makers, the agricultural and food industry, healthcare organizations, and advocacy/non-profit organizations - to implement changes to improve the health of all Americans," said co-senior author Renata Micha of the Friedman School of Nutrition Science and Policy at Tufts.

Three dietary factors contributed most to these costs: consumption of processed meats, low consumption of nuts/seeds, and low consumption of seafoods containing omega-3 fats.

The team notes that the current study may underestimate the cost of unhealthy diet habits as dietary factors may contribute to risk of diseases beyond heart disease, stroke and diabetes, such as cancer. While the study focuses on 10 dietary factors for which there were robust data, others may influence risk and cost as well. In addition, the study relied on dietary intake data collected from food questionnaires that asked respondents to recall what foods they had consumed in the past 24 hours. Respondents may have underreported unhealthy food choices or inaccurately recalled what they had consumed.

"Our work illustrates the need for interventions or policies that incentivize healthier dietary behavior as these changes have the potential to have a big impact and reduce the health and financial burden of cardiometabolic disease," said Gaziano.
-end-
This research was supported by the National Institutes of Health, and the National Heart, Lung, and Blood Institute (R01 HL130735). Micha is a principal investigator of a research grant from Unilever on an investigator-initiated project to assess the effects of omega-6 fatty acid biomarkers on diabetes and heart disease, and reports personal fees from the World Bank and Bunge. Gaziano reports research funding from Novartis and personal fees for consulting from the World Health Organization and Amgen. Co-authors report consulting for the Dairy Management Institute, Unilever, Nestle, PepsiCo, and the Bell Institute (General Mills), research funding from the Gates Foundation, personal fees for ad hoc consulting from GOED, Nutrition Impact, Bunge, Indigo Agriculture, Amarin, Acasti Pharma, Cleveland Clinic Foundation, America's Test Kitchen, and Danone; scientific advisory board, DayTwo, Elysium Health, Filtricine, and Omada Health; and chapter royalties from UpToDate. This study was performed as part of the Food Policy Review and Intervention Cost Effectiveness (Food-PRICE) work.

Brigham Health, a global leader in creating a healthier world, consists of Brigham and Women's Hospital, Brigham and Women's Faulkner Hospital, the Brigham and Women's Physicians Organization and many related facilities and programs. With more than 1,000 inpatient beds, approximately 60,000 inpatient stays and 1.7 million outpatient encounters annually, Brigham Health's 1,200 physicians provide expert care in virtually every medical and surgical specialty to patients locally, regionally and around the world. An international leader in basic, clinical and translational research, Brigham Health has nearly 5,000 scientists, including physician-investigators, renowned biomedical researchers and faculty supported by over $700 million in funding. The Brigham's medical preeminence dates back to 1832, and now, with 19,000 employees, that rich history is the foundation for its commitment to research, innovation, and community. Boston-based Brigham and Women's Hospital is a teaching affiliate of Harvard Medical School and dedicated to educating and training the next generation of health care professionals. For more information, resources, and to follow us on social media, please visit brighamandwomens.org.

Brigham and Women's Hospital

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.